Matricellular proteins in the trabecular meshwork

Experimental Eye Research

Volumn 88, Issue 4, 2009, Pages 694-703

  Rhee, Douglas J ^a   Haddadin, Ramez I ^a   Kang, Min Hyung ^a   Oh, Dong Jin ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

extracellular matrix; galectin; hevin; matricellular proteins; osteopontin; SPARC; tenascin; thrombospondin; trabecular meshwork

Indexed keywords

GALECTIN; LECTIN; OSTEONECTIN; OSTEOPONTIN; TENASCIN; THROMBOSPONDIN 1; THROMBOSPONDIN 2;

EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; TRABECULAR MESHWORK; TURNOVER TIME;

AGED; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; EYE PROTEINS; HUMANS; MALE; TRABECULAR MESHWORK;

EID: 64249149431     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.11.032     Document Type: Review

References (200)

1. Acott T.S., and Kelley M.J. Extracellular matrix in the trabecular meshwork. Exp. Eye Res. 86 (2008) 543-561
2. Adams J.C. Thrombospondins: multifunctional regulators of cell interactions. Annu. Rev. Cell Dev. Biol. 17 (2001) 25-51
3. Adams J.C., and Lawler J. The thrombospondin family. Curr. Biol. 3 (1993) 188-190
4. Adams J.C., and Lawler J. The thrombospondins. Int. J. Biochem. Cell Biol. 36 (2004) 961-968
5. Adams L., Scott G.K., and Weinberg C.S. Biphasic modulation of cell growth by recombinant human galectin-1. Biochim. Biophys. Acta 1312 (1996) 137-144
6. Aihara M., Lindsey J.D., and Weinreb R.N. Ocular hypertension in mice with a targeted type I collagen mutation. Invest. Ophthalmol. Vis. Sci. 44 (2003) 1581-1585
7. Alge C.S., Priglinger S.G., Kook D., Schmid H., Haritoglou C., Welge-Lussen U., and Kampik A. Galectin-1 influences migration of retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 47 (2006) 415-426
8. Allanore Y., Wipff J., Kahan A., and Boileau C. Genetic basis for systemic sclerosis. Joint Bone Spine 74 (2007) 577-583
9. Anthony T.L., Lindsey J.D., and Weinreb R.N. Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells. Invest. Ophthalmol. Vis. Sci. 43 (2002) 3705-3711
10. Baenziger N.L., Brodie G.N., and Majerus P.W. A thrombin-sensitive protein of human platelet membranes. Proc. Natl. Acad. Sci. U.S.A. 68 (1971) 240-243
11. Baenziger N.L., Brodie G.N., and Majerus P.W. Isolation and properties of a thrombin-sensitive protein of human platelets. J. Biol. Chem. 247 (1972) 2723-2731
12. Barany E.H., and Scotchbrook S. Influence of testicular hyaluronidase on the resistance to flow through the angle of the anterior chamber. Acta Physiol. Scand. 30 (1954) 240-278
13. Barany E.H., and Woodin A.M. Hyaluronic acid and hyaluronidase in the aqueous humour and the angle of the anterior chamber. Acta Physiol. Scand. 33 (1954) 257-290
14. Barker T.H., Baneyx G., Cardo-Vila M., Workman G.A., Weaver M., Menon P.M., Dedhar S., Rempel S.A., Arap W., Pasqualini R., Vogel V., and Sage E.H. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J. Biol. Chem. 280 (2005) 36483-36493
15. Barker T.H., Framson P., Puolakkainen P.A., Reed M., Funk S.E., and Sage E.H. Matricellular homologs in the foreign body response: hevin suppresses inflammation, but hevin and SPARC together diminish angiogenesis. Am. J. Pathol. 166 (2005) 923-933
16. Bassuk J.A., Birkebak T., Rothmier J.D., Clark J.M., Bradshaw A., Muchowski P.J., Howe C.C., Clark J.I., and Sage E.H. Disruption of the SPARC locus in mice alters the differentiation of lenticular epithelial cells and leads to cataract formation. Exp. Eye Res. 68 (1999) 321-331
17. Baum L.G., Seilhamer J.J., Pang M., Levine W.B., Beynon D., and Berliner J.A. Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation. Glycoconj. J. 12 (1995) 63-68
18. Bein K., and Simons M. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity. J. Biol. Chem. 275 (2000) 32167-32173
19. Berryhill B.L., Kane B., Stramer B.M., Fini M.E., and Hassell J.R. Increased SPARC accumulation during corneal repair. Exp. Eye Res. 77 (2003) 85-92
20. Bill A. The drainage of aqueous humor. Invest. Ophthalmol. Vis. Sci. 14 (1975) 1-3
21. Bill A., and Phillips C.I. Uveoscleral drainage of aqueous humour in human eyes. Exp. Eye Res. 12 (1971) 275-281
22. Blazejewski S., Le Bail B., Boussarie L., Blanc J.F., Malaval L., Okubo K., Saric J., Bioulac-Sage P., and Rosenbaum J. Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts. Am. J. Pathol. 151 (1997) 651-657
23. Bleiman B.S., and Schwartz A.L. Paradoxical intraocular pressure response to pilocarpine. A proposed mechanism and treatment. Arch. Ophthalmol. 97 (1979) 1305-1306
24. Bornstein P. Matricellular proteins: an overview. Matrix Biol. 19 (2000) 555-556
25. Bornstein P. Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 107 (2001) 929-934
26. Bornstein P., and Sage E.H. Matricellular proteins: extracellular modulators of cell function. Curr. Opin. Cell Biol. 14 (2002) 608-616
27. Bourdon M.A., Wikstrand C.J., Furthmayr H., Matthews T.J., and Bigner D.D. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res. 43 (1983) 2796-2805
28. Bradley J.M.B., Vranka J., Colvis C.M., Conger D.M., Alexander J.P., Fisk A.S., Samples J.R., and Acott T.S. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest. Ophthalmol. Vis. Sci. 39 (1996) 2649-2658
29. Bradshaw A.D., Graves D.C., Motamed K., and Sage E.H. SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6045-6050
30. Bradshaw A.D., Puolakkainen P., Dasgupta J., Davidson J.M., Wight T.N., and Sage E.H. SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J. Invest. Dermatol. 120 (2003) 949-955
31. Bradshaw A.D., Reed M.J., and Sage E.H. SPARC-null mice exhibit accelerated cutaneous wound closure. J. Histochem. Cytochem. 50 (2002) 1-10
32. Brekken R.A., and Sage E.H. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 19 (2001) 816-827
33. Brekken R.A., Sullivan M.M., Workman G., Bradshaw A.D., Carbon J., Siadak A., Murri C., Framson P.E., and Sage E.H. Expression and characterization of murine hevin (SC1), a member of the SPARC family of matricellular proteins. J. Histochem. Cytochem. 52 (2004) 735-743
34. Burch G.H., Gong Y., Liu W., Dettman R.W., Curry C.J., Smith L., Miller W.L., and Bristow J. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet. 17 (1997) 104-108
35. Canning P., Glenn J.V., Hsu D.K., Liu F.T., Gardiner T.A., and Stitt A.W. Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes. Exp. Diabetes Res. 2007 (2007) 51837-51846
36. Cao Z., Said N., Amin S., Wu H.K., Bruce A., Garate M., Hsu D.K., Kuwabara I., Liu F.T., and Panjwani N. Galectins-3 and -7, but not galectin-1, play a role in re-epithelialization of wounds. J. Biol. Chem. 277 (2002) 42299-42305
37. Cao Z., Said N., Wu H.K., Kuwabara I., Liu F.T., and Panjwani N. Galectin-7 as a potential mediator of corneal epithelial cell migration. Arch. Ophthalmol. 121 (2003) 82-86
38. Chen Y., Kelley M.J., and Acott T. DNA microarray analysis of gene expression in trabecular meshwork cells in response to TNFα and IL-1α. Invest. Ophthalmol. Vis. Sci. 46 (2005) (abstract #1349)
39. Chiquet M., and Fambrough D.M. Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J. Cell Biol. 98 (1984) 1937-1946
40. Chiquet-Ehrismann R. Tenascins, a growing family of extracellular matrix proteins. Experientia 51 (1995) 853-862
41. Chiquet-Ehrismann R. Tenascins. Int. J. Biochem. Cell Biol. 36 (2004) 986-990
42. Chiquet-Ehrismann R., and Chiquet M. Tenascins: regulation and putative functions during pathological stress. J. Pathol. 200 (2003) 488-499
43. Chiquet-Ehrismann R., Kalla P., Pearson C.A., Beck K., and Chiquet M. Tenascin interferes with fibronectin action. Cell 53 (1988) 383-390
44. Cockburn C.G., and Barnes M.J. Characterization of thrombospondin binding to collagen (type I) fibres: role of collagen telopeptides. Matrix 11 (1991) 168-176
45. Colnot C., Fowlis D., Ripoche M.A., Bouchaert I., and Poirier F. Embryonic implantation in galectin 1/galectin 3 double mutant mice. Dev. Dyn. 211 (1998) 306-313
46. Crawford K., and Kaufman P.L. Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alpha. Arch. Ophthalmol. 105 (1987) 1112-1116
47. Crawford S.E., Stellmach V., Murphy-Ullrich J.E., Ribeiro S.M., Lawler J., Hynes R.O., Boivin G.P., and Bouck N. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93 (1998) 1159-1170
48. Dahm R., Bramke S., Dawczynski J., Nagaraj R.H., and Kasper M. Developmental aspects of galectin-3 expression in the lens. Histochem. Cell Biol. 119 (2003) 219-226
49. Delany A.M., Amling M., Priemel M., Howe C., Baron R., and Canalis E. Osteopenia and decreased bone formation in osteonectin-deficient mice. J. Clin. Invest. 105 (2000) 915-923
50. Delany A.M., McMahon D.J., Powell J.S., Greenberg D.A., and Kurland E.S. Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis. Osteoporos. Int. (2007) (Epub ahead of print)
51. Denhardt D.T., and Guo X. Osteopontin: a protein with diverse functions. FASEB J. 7 (1993) 1475-1482
52. Diskin S., Cao Z., Leffler H., and Panjwani N. The Role of integrin glycosylation in galectin-8-mediated trabecular meshwork cell adhesion and spreading. Glycobiology Oct 11 (2008) (Epub ahead of print)
53. Elefteriou F., Exposito J.Y., Garrone R., and Lethias C. Binding of tenascin-X to decorin. FEBS Lett. 495 (2001) 44-47
54. Elola M.T., Wolfenstein-Todel C., Troncoso M.F., Vasta G.R., and Rabinovich G.A. Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Mol. Life Sci. 64 (2007) 1679-1700
55. El-Shabrawi Y., Eckhardt M., Berghold A., Faulborn J., Auboeck L., Mangge H., and Ardjomand N. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone. Eye 14 (2000) 375-383
56. Epstein D.L., Freddo T.F., Bassett-Chu S., Chung M., and Karageuzian L. Influence of ethacrynic acid on outflow facility in the monkey and calf eye. Invest. Ophthalmol. Vis. Sci. 28 (1987) 2067-2075
57. Epstein D.L., and Rohen J.W. Morphology of the trabecular meshwork and inner wall endothelium after cationized ferritin perfusion in the monkey eye. Invest. Ophthalmol. Vis. Sci. 32 (1991) 160-171
58. Erickson-Lamy K., Schroeder A., and Epstein D.L. Ethacrynic acid induces a reversible shape change and cytoskeletal changes in cultured cells. Invest. Ophthalmol. Vis. Sci. 33 (1992) 2631-2640
59. Ethier C.R., Kamm R.D., Palaszewski B.A., Johnson M.C., and Richardson T.M. Calculations of flow resistance in the juxtacanalicular meshwork. Invest. Ophthalmol. Vis. Sci. 27 (1986) 1741-1750
60. Fautsch M.P., Silva A.O., and Johnson D.H. Carbohydrate binding proteins galectin-1 and galectin-3 in human trabecular meshwork. Exp. Eye. Res. 77 (2003) 11-16
61. Feugate J.E., Wong L., Li Q.J., and Martins-Green M. The CXC chemokine cCAF stimulates precocious deposition of ECM molecules by wound fibroblasts, accelerating development of granulation tissue. BMC Cell Biol. 10 (2002) 3-13
62. Fleenor D.L., Shepard A.R., Hellberg P.E., Jacobson N., Pang I.-H., and Clark A.F. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest. Ophthalmol. Vis. Sci. 47 (2006) 226-234
63. Flück M., Chiquet M., Schmutz S., Mayet-Sornay M.H., and Desplanches D. Reloading of atrophied rat soleus muscle induces tenascin-C expression around damaged muscle fibers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (2003) 792-801
64. Flugel-Koch C., Ohlmann A., Fuchshofer R., Welge-Lussen U., and Tamm E.R. Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone in vitro. Exp. Eye Res. 79 (2004) 649-663
65. Forsberg E., Hirsch E., Fröhlich L., Meyer M., Ekblom P., Aszodi A., Werner S., and Fässler R. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 6594-6599
66. Framson P.E., and Sage E.H. SPARC and tumor growth: where the seed meets the soil?. J. Cell Biochem. 92 (2004) 679-690
67. Frizell E., Liu S.L., Abraham A., Ozaki I., Eghbali M., Sage E.H., and Zern M.A. Expression of SPARC in normal and fibrotic livers. Hepatology 21 (1995) 847-854
68. Fuchshofer R., Welge-Lussen U., and Lutjen-Drecoll E. The effect of TGF_2 on human trabecular meshwork extracellular proteolytic system. Exp. Eye Res. 77 (2003) 757-765
69. Fuchshofer R., Yu A.H., Welge-Lüssen U., and Tamm E.R. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 48 (2007) 715-726
70. Fukamauchi F., Mataga N., Wang Y.J., Sato S., Youshiki A., and Kusakabe M. Abnormal behavior and neurotransmissions of tenascin gene knockout mouse. Biochem. Biophys. Res. Commun. 221 (1996) 151-156
71. Fukushima A., Sumi T., Fukuda K., Kumagai N., Nishida T., Okumura K., Akiba H., Yagita H., and Ueno H. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice. Int. Arch. Allergy Immunol. 146 (2008) 36-43
72. Gabius H.J. Animal lectins. Eur. J. Biochem. 243 (1997) 543-576
73. Galvin N.J., Vance P.M., Dixt V.M., Fink B., and Frazier W.A. Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. J. Cell Biol. 104 (1987) 1413-1422
74. Giachelli C.M., and Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol. 19 (2000) 615-622
75. Gilbert R.E., Cox A.J., Kelly D.J., Wilkinson-Berka J.L., Sage E.H., Jerums G., and Cooper M.E. Localization of secreted protein acidic and rich in cysteine (SPARC) expression in the rat eye. Connect. Tissue Res. 40 (1999) 295-303
76. Gilles C., Bassuk J.A., Pulyaeva H., Sage E.H., Foidart J.M., and Thompson E.W. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res. 58 (1998) 5529-5536
77. Gilmour D.T., Lyon G.J., Carlton M.B., Sanes J.R., Cunningham J.M., Anderson J.R., Hogan B.L., Evans M.J., and Colledge W.H. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J. 17 (1998) 1860-1870
78. Girard J.P., and Springer T.A. Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules. J. Biol. Chem. 271 (1996) 4511-4517
79. Gottanka J., Chan D., Eichhorn M., Lutjen-Drecoll E., and Ethier C.R. Effects of TGF_2 in perfused human eyes. Invest. Ophthalmol. Vis. Sci. 45 (2004) 153-158
80. Grant W.M. Further studies on facility of flow through the trabecular meshwork. Arch. Ophthalmol. 60 (1958) 523-533
81. Graul T.A., Kwon Y.H., Zimmerman M.B., Kim C.S., Sheffield V.C., Stone E.M., and Alward W.L. A case-control comparison of the clinical characteristics of glaucoma and ocular hypertensive patients with and without the myocilin Gln368Stop mutation. Am. J. Ophthalmol. 134 (2002) 884-890
82. Gruber H.E., Ingram J.A., and Hanley Jr. E.N. Cellular immunohistochemical localization of the matricellular protein myocilin in the intervertebral disc. Biotech. Histochem. 81 (2006) 119-124
83. Gum G.G., Samuelson D.A., and Gelatt K.N. Effect of hyaluronidase on aqueous outflow resistance in normotensive and glaucomatous eyes of dogs. Am. J. Vet. Res. 53 (1992) 767-770
84. Haddadin R.I., Oh D.J., Gupta M., Sage E.H., and Rhee D.J. SPARC-null mice have lower intraocular pressures. Invest. Ophthalmol. Vis. Sci. (2008) (ARVO E-Abstract 1609)
85. Hambrock H.O., Nitsche D.P., Hansen U., Bruckner P., Paulsson M., Maurer P., and Hartmann U. SC1/hevin. An extracellular calcium-modulated protein that binds collagen I. J. Biol. Chem. 278 (2003) 11351-11358
86. Hankenson K.D., Bain S.D., Kyriakides T.R., Smith E.A., and Goldstein S.A. Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin-2. J. Bone Miner. Res. 15 (2000) 851-862
87. Hiscott P., Paraoan L., Choudhary A., Ordonez J.L., Al-Khaier A., and Armstrong D.J. Thrombospondin 1, thrombospondin 2 and the eye. Prog. Retin. Eye Res. 25 (2006) 1-18
88. Hiscott P., Schlötzer-Schrehardt U., and Naumann G.O. Unexpected expression of thrombospondin 1 by corneal and iris fibroblasts in the pseudoexfoliation syndrome. Hum. Pathol. 27 (1996) 1255-1258
89. Holmberg A. The fine structure of the inner wall of Schlemm's canal. Arch. Ophthalmol. 62 (1959) 956-958
90. Holmberg A. Schlemm's canal and the trabecular meshwork: an electron microscopic study of the normal structure in man and monkey (Cercopithecus aethiops). Doc. Ophthalmol. 19 (1965) 339-373
91. Inomata H., Bill S., and Smelser G.K. Aqueous humor pathways through the trabecular meshwork and into Schlemm's canal in the cynomolgus monkey (Macaca irus): an electron microscopic study. Am. J. Ophthalmol. 73 (1972) 760-789
92. Jaggi G.P., Laeng H.R., Müntener M., and Killer H.E. The anatomy of the muscle insertion (scleromuscular junction) of the lateral and medial rectus muscle in humans. Invest. Ophthalmol. Vis. Sci. 46 (2005) 2258-2263
93. Järvinen T.A., Jozsa L., Kannus P., Järvinen T.L., Kvist M., Hurme T., Isola J., Kalimo H., and Järvinen M. Mechanical loading regulates tenascin-C expression in the osteotendinous junction. J. Cell. Sci. 18 (1999) 3157-3166
94. Johnson D.H., and Tschumper R.C. Human trabecular meshwork organ culture. A new method. Invest. Ophthalmol. Vis. Sci. 28 (1987) 945-953
95. Johnson E.C., Jia L., Cepurna W.O., Doser T.A., and Morrison J.C. Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3161-3177
96. Johnston I.G., Paladino T., Gurd J.W., and Brown I.R. Molecular cloning of SC1 - a putative brain extracellular-matrix glycoprotein showing partial similarity to osteonectin/BM-40/SPARC. Neuron 4 (1990) 165-176
97. Kantorow M., Horwitz J., and Carper D. Up-regulation of osteonectin/SPARC in age-related cataractous human lens epithelia. Mol. Vis. 4 (1998) 17-23
98. Kantorow M., Huang Q., Yang X.J., Sage E.H., Magabo K.S., Miller K.M., and Horwitz J. Increased expression of osteonectin/SPARC mRNA and protein in age-related human cataracts and spatial expression in the normal human lens. Mol. Vis. 6 (2000) 24-29
99. Kase S., Yokoi M., Saito W., Furudate N., Ohgami K., Kitamura M., Kitaichi N., Yoshida K., Kase M., Ohno S., and Uede T. Increased osteopontin levels in the vitreous of patients with diabetic retinopathy. Ophthalmic. Res. 39 (2007) 143-147
100. Keller K.E., Bradley J.M., Kelley M.J., and Acott T.S. Effects of modifiers of glycosaminoglycan biosynthesis on outflow facility in perfusion culture. Invest. Ophthalmol. Vis. Sci. 49 (2008) 2495-2505
101. Keller K.E., Kelley M.J., and Acott T.S. Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching. Invest. Ophthalmol. Vis. Sci. 48 (2007) 1164-1172
102. Knepper P.A., Farbman A.I., and Telser A.G. Exogenous hyaluronidases and degradation of hyaluronic acid in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 25 (1984) 286-293
103. Kyriakides T.R., Tam J.Y.W., and Bornstein P. Accelerated wound healing in mice with a disruption of the thrombospondin-2 gene. J. Invest. Dermatol. 113 (1999) 782-787
104. Kyriakides T.R., Zhu Y.H., Smith L.T., Bain S.D., and Yang Z. Mice that lack thrombospondin-2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density and a bleeding diathesis. J. Cell. Biol. 140 (1998) 419-430
105. Lee W.R., Grierson I., and McMenamin P.G. The morphological response of the primate outflow system to changes in pressure and flow. In: Lutjen-Drecholl E. (Ed). Basic Aspects of Glaucoma Research (1982), Schattauer Verlag, Stuttgart
106. Lethias C., Elefteriou F., Parsiegla G., Exposito J.Y., and Garrone R. Identification and characterization of a conformational heparin-binding site involving two fibronectin type III modules of bovine tenascin-X. J. Biol. Chem. 276 (2001) 16432-16438
107. Li Y., Arcoca-Aguilar D.J., Ghosh S., Sanchez-Sanchez F., Escribano J., and Coca-Prados M. Interaction of myocilin with the C-terminal region of hevin. Biochem. Biophys. Res. Commun. 339 (2006) 797-804
108. Liaw L., Birk D.E., Ballas C.B., Whitsitt J.S., Davidson J.M., and Hogan B.L. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest. 101 (1998) 1468-1478
109. Lindsey J.D., Kashiwagi K., Boyle D., Kashiwagi F., Firestein G.S., and Weinreb R.N. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr. Eye Res. 15 (1996) 869-875
110. Liu X., Wu Z., Sheibani N., Brandt C.R., Polansky J.R., and Kaufman P.L. Low dose latrunculin-A inhibits dexamethasone-induced changes in the actin cytoskeleton and alters extracellular matrix protein expression in cultured human trabecular meshwork cells. Exp. Eye Res. 77 (2003) 181-188
111. 2. Exp. Eye Res. 47 (1988) 761-769
112. 2-1-isopropylester on anterior segment morphology. In: Bito L.Z., and Stjernschantz J. (Eds). The Ocular Effects of Prostaglandins and Other Eicosanoids (1989), Allan R. Liss Inc., New York 737-776
113. Lutjen-Drecoll E., Wiendl H., and Kaufman P.L. Acute and chronic structural effects of pilocarpine on monkey outflow tissues. Trans. Am. Ophthalmol. Soc. 96 (1998) 171-191 (discussion: 192-5)
114. Mackie E.J., and Tucker R.P. The tenascin-C knockout revisited. J. Cell Sci. 112 (1999) 3847-3853
115. Maepea O., and Bill A. The pressures in the episcleral veins, Schlemm's canal and trabecular meshwork in monkeys: effects of changes in intraocular pressure. Exp. Eye Res. 49 (1989) 645-663
116. Maepea O., and Bill A. Pressures in the juxtacanalicular tissue and Schlemm's canal in monkeys. Exp. Eye Res. 54 (1992) 879-883
117. Magee R.M., Hagan S., Hiscott P.S., Sheridan C.M., Carron J.A., McGalliard J., and Grierson I. Synthesis of osteonectin by human retinal pigment epithelial cells is modulated by cell density. Invest. Ophthalmol. Vis. Sci. 41 (2000) 2707-2711
118. Makhluf H.A., Stepniakowska J., Hoffman S., Smith E., LeRoy E.C., and Trojanowska M. IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts. J. Invest. Dermatol. 107 (1996) 856-859
119. Mao J.R., Taylor G., Dean W.B., Wagner D.R., Afzal V., Lotz J.C., Rubin E.M., and Bristow J. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat. Genet. 30 (2002) 421-425
120. Matarrese P., Fusco O., Tinari N., Natoli C., Liu F.T., Semeraro M.L., Malorni W., and Iacobelli S. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int. J. Cancer 85 (2000) 545-554
121. Matsuda A., Yoshiki A., Tagawa Y., Matsuda H., and Kusakabe M. Corneal wound healing in tenascin knockout mouse. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1071-1080
122. Matsumoto K., Saga Y., Ikemura T., Sakakura T., and Chiquet-Ehrismann R. The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. J. Cell Biol. 125 (1994) 483-493
123. McClung H.M., Thomas S.L., Osenkowski P., Toth M., Menon P., Raz A., Fridman R., and Rempel S.A. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavate of galectin-3 in U87MG glioma cells. Neurosci. Lett. 419 (2007) 172-177
124. McPherson J., Sage H., and Bornstein P. Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture. Apparent identity with platelet thrombospondin. J. Biol. Chem. 256 (1981) 11330-11336
125. Mishima H., Hibino T., Hara H., Murakami J., and Otori T. SPARC from corneal epithelial cells modulates collagen contraction by keratocytes. Invest. Ophthalmol. Vis. Sci. 39 (1998) 2547-2553
126. Mitamura Y., Takeuchi S., Ohtsuka K., Matsuda A., Hiraiwa N., and Kusakabe M. Tenascin-C levels in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Care 25 (2002) 1899
127. Mitamura Y., Takeuchi S., Ohtsuka K., Matsuda A., Yamamoto T., Yamamoto S., Hiraiwa N., and Kusakabe M. Tenascin-C levels in the vitreous of patients with proliferative vitreoretinopathy. Ophthalmologica 217 (2003) 422-425
128. Miyazaki K., Okada Y., Yamanaka O., Kitano A., Ikeda K., Kon S., Uede T., Rittling S.R., Denhardt D.T., Kao W.W., and Saika S. Corneal wound healing in an osteopontin-deficient mouse. Invest. Ophthalmol. Vis. Sci. 49 (2008) 1367-1375
129. Moses R.A., Grodzki W.J., Etheridge E.L., and Wilson C.D. Schlemm's canal: the effect of intraocular pressure. Invest. Ophthalmol. Vis. Sci. 20 (1981) 61-68
130. Mumby S.M., Raugi G.J., and Bornstein P. Interactions of thrombospondin with extracellular matrix proteins: selective binding to type V collagen. J. Cell Biol. 98 (1984) 646-652
131. Murphy-Ullrich J.E., Schultz-Cherry S., and Hook M. Transforming growth factor-beta complexes with thrombospondin. Mol. Biol. Cell. 3 (1992) 181-188
132. Nakken K.E., Nygård S., Haalang T., Berge K.E., Arnkvaern K., Ødegaard A., Labori K.J., and Raeder M.G. Multiple inflammatory-, tissue remodeling- and fibrosis genes are differentially transcribed in the livers of Abcb4 (-/-) mice harboring chronic cholangitis. Scand. J. Gastroenterol. 42 (2007) 1245-1255
133. Nangia-Makker P., Raz T., Tait L., Hogan V., Fridman R., and Raz A. Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers. Cancer Res. 67 (2007) 11760-11768
134. Nelson P.S., Plymate S.R., Wang K., True L.D., Ware J.L., Gan L., Liu A.Y., and Hood L. Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma. Cancer Res. 58 (1998) 232-236
135. Nilsson S.F. The uveoscleral outflow routes. Eye 11 (1997) 149-154 (review)
136. Norose K., Clark J.I., Syed N.A., Basu A., Heber-Katz E., Sage E.H., and Howe C.C. SPARC deficiency leads to early-onset cataractogenesis. Invest. Ophthalmol. Vis. Sci. 39 (1998) 2674-2680
137. Ochiai Y., and Ochiai H. Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn. J. Ophthalmol. 46 (2002) 249-253
138. Ocklind A. Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections. Exp. Eye Res. 67 (1998) 179-191
139. Ogden A.T., Nunes I., Ko K., Wu S., Hines C.S., Wang A.F., Hegde R.S., and Lang R.A. GRIFIN, a novel lens-specific protein related to the galectin family. J. Biol. Chem. 273 (1998) 28889-28896
140. Ohannesian D.W., Lotan D., Thomas P., Jessup J.M., Fukuda M., Gabius H.J., and Lotan R. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res. 55 (1995) 2191-2199
141. Oldberg A., Franzén A., and Heinegård D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc. Natl. Acad. Sci. U.S.A 83 (1986) 8819-8823
142. O'Regan A., and Berman J.S. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int. J. Exp. Pathol. 81 (2000) 373-390
143. Orend G., and Chiquet-Ehrismann R. Adhesion modulation by antiadhesive molecules of the extracellular matrix. Exp. Cell Res. 261 (2000) 104-110
144. Ortega N., Behonick D.J., Colnot C., Cooper D.N., and Werb Z. Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. Mol. Biol. Cell 16 (2005) 3028-3039
145. Ozcan A.A., Ozdemir N., and Canataroglu A. The aqueous levels of TGF-beta2 in patients with glaucoma. Int. Ophthalmol. 25 (2004) 19-22
146. Ozeki Y., Matsui T., Yamamoto Y., Funahashi M., Hamako J., and Titani K. Tissue fibronectin is an endogenous ligand for galectin-1. Glycobiology 5 (1995) 255-261
147. Pang I.H., Fleenor D.L., Hellberg P.E., Stropki K., McCartney M.D., and Clark A.F. Aqueous outflow-enhancing effect of tert-butylhydroquinone: involvement of AP-1 activation and MMP-3 expression. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3502-3510
148. Pearson C.A., Pearson D., Shibahara S., Hofsteenge J., and Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-beta. EMBO J. 7 (1988) 2977-2982
149. Pederson J.E., Gaasterland D.E., and MacLellan H.M. Uveoscleral aqueous outflow in the rhesus monkey: importance of uveal reabsorption. Invest. Ophthalmol. Vis. Sci. 16 (1977) 1008-1017
150. Penttinen R.P., Kobayashi S., and Bornstein P. Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc. Natl. Acad. Sci. U S A 85 (1988) 1105-1108
151. Perillo N.L., Marcus M.E., and Baum L.G. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J. Mol. Med. 76 (1998) 402-412
152. Peters D.M., Herbert K., Biddick B., and Peterson J.A. Myocilin binding to Hep II domain of fibronectin inhibits cell spreading and incorporation of paxillin into focal adhesions. Exp. Cell Res. 303 (2005) 218-228
153. Pichler R.H., Hugo C., Shankland S.J., Reed M.J., Bassuk J.A., Andoh T.F., Lombardi D.M., Schwartz S.M., Bennett W.M., Alpers C.E., Sage E.H., Johnson R.J., and Couser W.G. SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int. 50 (1996) 1978-1989
154. Picht G., Welge-Luessen U., Grehn F., and Lutjen-Drecholl E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch. Clin. Exp. Ophthalmol. 239 (2001) 199-207
155. Poirier F., and Robertson E.J. Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Development 119 (1993) 1229-1236
156. Puolakkainen P., Bradshaw A.D., Kyriakides T.R., Reed M., Brekken R., Wight T., Bornstein P., Ratner B., and Sage E.H. Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials. Am. J. Pathol. 162 (2003) 627-635
157. Rabinovich G.A., Riera C.M., Landa C.A., and Sotomayor C.E. Galectins: a key intersection between glycobiology and immunology. Braz. J. Med. Biol. Res. 32 (1999) 383-393
158. Rhee D.J., Fariss R.N., Brekken R., Sage E.H., and Russell P. The matricellular protein SPARC is expressed in human trabecular meshwork. Exp. Eye Res. 77 (2003) 601-607
159. Rittling S.R., and Denhardt D.T. Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp. Nephrol. 7 (1999) 103-113
160. Sage E.H., and Bornstein P. Extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin, and thrombospondin. J. Biol. Chem. 266 (1991) 14831-14834
161. Sage H., Vernon R.B., and Decker J. Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. J. Histochem. Cytochem. 37 (1989) 819-829
162. Saika S., Miyamoto T., Ishida I., Ohnishi Y., and Ooshima A. Osteopontin: a component of matrix in capsular opacification and subcapsular cataract. Invest. Ophthalmol. Vis. Sci. 44 (2003) 1622-1628
163. Schalkwijk J., Zweers M.C., Steijlen P.M., Dean W.B., Taylor G., van Vlijmen I.M., van Haren B., Miller W.L., and Bristow J. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. Eng. J. Med. 345 (2001) 1167-1175
164. Schroeder A., Erickson-Lamy K., and Epstein D.L. Ethacrynic acid induced changes in cytoskeletal tubulin. Invest. Ophthalmol. Vis. Sci. 30 Suppl. (1989) 356 (abstract)
165. Seiler T., and Wollensak J. The resistance of the trabecular meshwork to aqueous humor outflow. Graefes Arch. Clin. Exp. Ophthalmol. 223 (1985) 88-91
166. Senger D.R., Wirth D.F., and Hynes R.O. Transformed mammalian cells secrete specific proteins and phosphoproteins. Cell 16 (1979) 885-893
167. Shankavaram U.T., DeWitt D.L., Funk S.E., Sage E.H., and Wahl L.M. Regulation of human monocyte matrix metalloproteinases by SPARC. J. Cell. Physiol. 173 (1997) 327-334
168. Sipes J.M., Guo N., Negre E., Vogel T., Krutzsch H.C., and Roberts D.D. Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type I repeat of thrombospondin. J. Cell. Biol. 121 (1993) 467-477
169. Sodek J., Ganss B., and McKee M.D. Osteopontin. Crit. Rev. Oral Biol. Med. 11 (2000) 279-303
170. Soderling J.A., Reed M.J., Corsa A., and Sage E.H. Cloning and expression of murine SC1, a gene product homologous to SPARC. J. Histochem. Cytochem. 45 (1997) 823-835
171. Sullivan M.M., Barker T.H., Funk S.E., Karchin A., Seo N.S., Hook M.,
172. Taneda S., Pippin J.W., Sage E.H., Hudkins K.L., Takeuchi Y., Couser W.G., and Alpers C.E. Amelioration of diabetic nephropathy in SPARC-null mice. J. Am. Soc. Nephrol. 14 (2003) 968-980
173. Tanihara H., Ohira A., Takahashi M., Honda Y., and Suzuki S. Localization and possible gene expression of proteoglycan decorin in the trabecular meshwork. Curr. Eye Res. 14 (1995) 727-730
174. Termine J.D., Kleinman H.K., and Whitson S.W. Osteonectin, a bone specific protein linking mineral to collagen. Cell 26 (1981) 99-105
175. Tomarev S.I., Wistow G., Raymond V., Dubois S., and Malyukova I. Gene expression profile of the human trabecular meshwork: NEIBank sequence tag analysis. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2588-2596
176. Toris C.B., Zhan G.L., Zhao J., Camras C.B., and Yablonski M.E. Potential mechanism for the additivity of pilocarpine and latanoprost. Am. J. Ophthalmol. 131 (2001) 722-728
177. Tripathi R.C. Mechanism of the aqueous outflow across the trabecular wall of Schlemm's canal. Exp. Eye Res. 11 (1971) 116-121
178. Tripathi R.C., Li J., Chan W.F., and Tripathi B.J. Aqueous humor in glaucomatous eyes contains an increased level of TGFb2. Exp. Eye Res. 59 (1994) 723-727
179. Tuori A., Uusitalo H., Thornell L.E., Yoshida T., and Virtanen I. The expression of tenascin-X in developing and adult rat and human eye. Histochem. J. 31 (1999) 245-252
180. Ueda J., Wentz-Hunter K., and Yue B.Y. Distribution of myocilin and extracellular matrix components in the juxtacanalicular tissue of human eyes. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1068-1076
181. Ueda J., and Yue B.Y. Distribution of myocilin and extracellular matrix components in the corneoscleral meshwork of human eyes. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4772-4779
182. Unger S., and Hecht J.T. Pseudoachondroplasia and multiple epiphyseal dysplasia: new etiological developments. Am. J. Med. Genet. 106 (2001) 244-250
183. van den Brûle F.A., Buicu C., Baldet M., Sobel M.E., Cooper D.N., Marschal P., and Castronovo V. Galectin-1 modulates human melanoma cell adhesion to laminin. Biochem. Biophys. Res. Commun. 209 (1995) 760-767
184. Vittal V., Rose A., Gregory K.E., Kelly M.J., and Acott T.S. Changes in gene expression by trabecular meshwork cells in response to mechanical stretching. Invest. Ophthalmol. Vis. Sci. 46 (2005) 2857-2868
185. Wang Z., Handa J.T., Green W.R., Stark W.J., Weinberg R.S., and Jun A.S. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty. Ophthalmology 2007 114 (2007) 1453-1460
186. Warfield P.R., Makker P.N., Raz A., and Ochieng J. Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3. Invasion Metastasis 17 (1997) 101-112
187. Weinreb R.N., Kashiwagi K., Kashiwagi F., Tuskahara S., and Lindsey J.D. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest. Ophthalmol. Vis. Sci. 38 (1997) 2772-2780
188. Weinreb R.N., and Lindsey J.D. Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost. Invest. Ophthalmol. Vis. Sci. 43 (2002) 716-722
189. Wentz-Hunter K., Shen X., Okazaki K., Tanihara H., and Yue B.Y. Overexpression of myocilin in cultured human trabecular meshwork cells. Exp. Cell Res. 297 (2004) 39-48
190. Wirtz M.K., Bradley J.M., Xu H., Domreis J., Nobis C.A., Truesdale A.T., Samples J.R., Van Buskirk E.M., and Acott T.S. Proteoglycan expression by human trabecular meshworks. Curr. Eye Res. 16 (1997) 412-421
191. Yan Q., Clark J.I., and Sage E.H. Expression and characterization of SPARC in human lens and in the aqueous and vitreous humors. Exp. Eye Res. 71 (2000) 81-90
192. Yan Q., and Sage E.H. SPARC, a matricellular glycoprotein with important biology functions. J. Histochem. Cytochem. 47 (1999) 1495-1505
193. Yang Z., Strickland D.K., and Bornstein P. Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J. Biol. Chem. 276 (2001) 8403-8408
194. Yeung A.M., Schlötzer-Schrehardt U., Kulkarni B., Tint N.L., Hopkinson A., and Dua H.S. Limbal epithelial crypt: a model for corneal epithelial maintenance and novel limbal regional variations. Arch. Ophthalmol. 126 (2008) 665-669
195. Yoshitake H., Rittling S.R., Denhardt D.T., and Noda M. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc. Natl. Acad. Sci. U S A 96 (1999) 8156-8160
196. Zhao X., Ramsey K.E., Stephan D.A., and Russell P. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-β. Invest. Ophthalmol. Vis. Sci. 45 (2004) 4023-4034
197. Zhou Q., and Cummings R.D. The S-type lectin from calf heart tissue binds selectively to the carbohydrate chains of laminin. Arch. Biochem. Biophys. 281 (1990) 27-35
198. Zhou X., Tan F.K., Guo X., and Arnett F.C. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma. Arthritis Rheum. 54 (2006) 2626-3631
199. Zhou X.D., Xiong M.M., Tan F.K., Guo X.J., and Arnett F.C. SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor beta stimulation. Arthritis Rheum. 54 (2006) 3885-3889
200. Zick Y., Eisenstein M., Goren R.A., Hadari Y.R., Levy Y., and Ronen D. Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj. J. 19 (2004) 517-526